Patents by Inventor Yanhua HU

Yanhua HU has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • MEASUREMENT RELAXATION METHOD AND APPARATUS, STORAGE MEDIUM, AND DEVICE
    Publication number: 20250097742
    Abstract: A measurement relaxation method includes: obtaining a relaxation command message sent by a base station, and performing measurement relaxation on the basis of the relaxation command message.
    Type: Application
    Filed: January 11, 2022
    Publication date: March 20, 2025
    Inventors: Yanhua LI, Ziquan HU
  • MEASUREMENT RELAXTION METHOD, DEVICE APPARATUS, STORAGE MEDIUM AND APPARATUS
    Publication number: 20250097839
    Abstract: A measurement relaxation method is provided. The method includes: configuring a measurement relaxation criterion to a UE. The measurement relaxation criterion may be at least one of a Radio Link Monitoring (RLM) measurement relaxation criterion, a Beam Failure Detection (BFD) measurement relaxation criterion, or a Radio Resource management (RRM) measurement relaxation criterion.
    Type: Application
    Filed: January 11, 2022
    Publication date: March 20, 2025
    Inventors: Yanhua LI, Ziquan HU
  • MEASUREMENT RELAXATION METHOD AND DEVICE
    Publication number: 20250088885
    Abstract: A measurement relaxation method is performed by a user equipment (UE), and includes: obtaining at least one relaxation criterion of a first version configured by a network device; and performing a measurement relaxation operation, wherein the UE meets one or more relaxation criteria of the at least one relaxation criterion of the first version.
    Type: Application
    Filed: January 7, 2022
    Publication date: March 13, 2025
    Inventors: Ziquan HU, Yanhua LI
  • METHODS FOR DETERMINING RESPONSIVENESS TO TYK2 INHIBITORS
    Publication number: 20240390369
    Abstract: Disclosed are methods of treating psoriatic arthritis in a subject comprising administering to the subject a TYK2 inhibitor (e.g., deucravacitinib), wherein the methods depend on whether the subject exhibits certain levels of specific proteins in the blood (e.g., plasma or serum) prior to or early during administration of the TYK2 inhibitor. Also disclosed are methods for selecting subjects suffering from psoriatic arthritis for treatment with a TYK2 inhibitor, wherein subjects are selected based on the level of one or more proteins in the blood prior to treatment with a TYK2 inhibitor.
    Type: Application
    Filed: September 29, 2022
    Publication date: November 28, 2024
    Inventors: Yanhua Hu, Lu Gao, Ian MacQuarie Catlett, Xiang Guo
  • Method to monitor pharmacodynamic responses mediated by in vivo administration of glucocorticoids
    Patent number: 11421278
    Abstract: The present invention relates generally to a method of monitoring pharmacodynamic responses mediated by in vivo administration of glucocorticoids. More specifically, the present invention relates to a method of using a change in gene signature as a pharmacodynamic marker of glucocorticoid exposure.
    Type: Grant
    Filed: August 28, 2018
    Date of Patent: August 23, 2022
    Assignee: BRISTOL-MYERS SQUIBB COMPANY
    Inventors: Julie Carman, Yanhua Hu
  • A METHOD TO MONITOR PHARMACODYNAMIC RESPONSES MEDIATED BY IN VIVO ADMINISTRATION OF GLUCOCORTICOIDS
    Publication number: 20200299770
    Abstract: The present invention relates generally to a method of monitoring pharmacodynamic responses mediated by in vivo administration of glucocorticoids. More specifically, the present invention relates to a method of using a change in gene signature as a pharmacodynamic marker of glucocorticoid exposure.
    Type: Application
    Filed: August 28, 2018
    Publication date: September 24, 2020
    Applicant: BRISTOL-MYERS SQUIBB COMPANY
    Inventors: Julie CARMAN, Yanhua HU